Hwg Holdings LP Abb Vie Inc. Transaction History

Hwg Holdings LP

$283 Million
Q3 2024

A detailed history of Hwg Holdings LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Hwg Holdings LP holds 1,084 shares of ABBV stock, worth $190,328. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,084

Previous 1,061 2.17%

Holding current value

$190,328

Previous $181,000 18.23%

% of portfolio

0.08%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $177,602 - $216,073	1,084 New	1,084 $214,000
Q2 2024 Aug 19, 2024	BUY	$154.79 - $180.76 $8,977 - $10,484	58 Added 5.78%	1,061 $181,000
Q4 2023 Jan 04, 2024	SELL	$137.6 - $154.97 $1,238 - $1,394	-9 Reduced 0.89%	1,003 $155,000
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $6,278 - $7,268	47 Added 4.87%	1,012 $150,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $19,081 - $23,745	-144 Reduced 12.98%	965 $130,000
Q1 2023 May 16, 2023	SELL	$144.61 - $166.54 $2.2 Million - $2.54 Million	-15,226 Reduced 93.21%	1,109 $176,000
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $252,139 - $302,381	1,823 Added 12.56%	16,335 $2.64 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $31,405 - $36,019	234 Added 1.64%	14,512 $1.95 Million
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $1.05 Million - $1.31 Million	7,979 Added 126.67%	14,278 $2.32 Million
Q4 2021 Feb 17, 2022	BUY	$107.43 - $135.93 $375,360 - $474,939	3,494 Added 124.56%	6,299 $853,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $44,188 - $49,228	420 Added 17.61%	2,805 $316,000
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $167,976 - $184,922	-1,642 Reduced 40.77%	2,385 $258,000
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $23,100 - $31,188	-287 Reduced 6.65%	4,027 $431,000
Q3 2020 Oct 02, 2020	SELL	$85.91 - $100.83 $191,063 - $224,245	-2,224 Reduced 34.02%	4,314 $378,000
Q2 2020 Aug 17, 2020	BUY	$73.37 - $98.18 $479,693 - $641,900	6,538 New	6,538 $642,000
Q3 2019 Nov 20, 2019	SELL	$62.98 - $75.72 $15,745 - $18,930	-250 Closed	0 $0
Q2 2018 Aug 20, 2018	SELL	$89.78 - $106.23 $884,692 - $1.05 Million	-9,854 Reduced 97.53%	250 $23,000
Q1 2018 Apr 27, 2018	BUY	$92.01 - $123.21 $906,666 - $1.21 Million	9,854 Added 3941.6%	10,104 $956,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $17,462 - $22,305	250	250 $22,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hwg Holdings LP, based on Form 13F filings with the SEC.

News

Stay updated on Hwg Holdings LP with notifications on news.

Account